Recent advance of fluorescent probes for detection of drug-induced liver injury markers

被引:21
|
作者
Sun, Dongqin [1 ]
Chen, Zhenzhen [1 ]
Hu, Jiali [1 ]
Zeng, Huajin [1 ]
Qu, Lingbo [2 ]
Yang, Ran [2 ]
机构
[1] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
[2] Zhengzhou Univ, Coll Chem, Zhengzhou 450001, Peoples R China
基金
中国国家自然科学基金;
关键词
Fluorescent probe; Drug-induced liver injury (DILI); Roussel uclaf causality assessment method (RUCAM); Clinical markers; Imaging; GLUTATHIONE-S-TRANSFERASE; IMAGING ENDOGENOUS PEROXYNITRITE; HIGHLY SELECTIVE DETECTION; ALANINE AMINOTRANSFERASE; INDUCED HEPATOTOXICITY; ENDOPLASMIC-RETICULUM; BIOLUMINESCENT PROBE; CAUSALITY ASSESSMENT; HYPOCHLOROUS ACID; ADVERSE REACTIONS;
D O I
10.1016/j.cclet.2021.12.043
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug-induced liver injury (DILI) is a common and serious adverse drug reaction. At present, DILI is perfectly diagnozed in clinical settings using Roussel Uclaf causality assessment method (RUCAM) in its original version published 1993 and its updated version published 2016, well established worldwide as a diagnostic algorithm with a high sensitivity and specificity. Nevertheless, the search for additional detection methods supporting RUCAM continues. In recent years, with the development of optical imaging technology, fluorescent probes have gradually shown great advantages in the detection and diagnosis of DILI markers such as high sensitivity, anti-interference, real-time monitoring and non-invasive measurement. In this review, the recent advances of fluorescent probes for evaluation of DILI in experimental studies were summarized according to various markers of DILI. We believe that learning about the design and practical application of these probes will contribute to the further development of detection sensors for DILI markers. (C) 2022 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页码:4478 / 4494
页数:17
相关论文
共 50 条
  • [41] The transformation in biomarker detection and management of drug-induced liver injury
    Church, Rachel J.
    Watkins, Paul B.
    LIVER INTERNATIONAL, 2017, 37 (11) : 1582 - 1590
  • [42] Predicting idiosyncratic drug-induced liver injury - some recent advances
    Chen, Minjun
    Borlak, Juergen
    Tong, Weida
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 721 - 723
  • [43] Drug-induced liver injury: recent advances in diagnosis and risk assessment
    Kullak-Ublick, Gerd A.
    Andrade, Raul J.
    Merz, Michael
    End, Peter
    Benesic, Andreas
    Gerbes, Alexander L.
    Aithal, Guruprasad P.
    GUT, 2017, 66 (06) : 1154 - 1164
  • [44] Fluorescent probe for the imaging of superoxide and peroxynitrite during drug-induced liver injury
    Wu, Luling
    Liu, Jihong
    Tian, Xue
    Groleau, Robin R.
    Bull, Steven D.
    Li, Ping
    Tang, Bo
    James, Tony D.
    CHEMICAL SCIENCE, 2021, 12 (11) : 3921 - 3928
  • [45] DRUG-INDUCED LIVER-INJURY
    MITCHELL, JR
    LAUTERBURG, BH
    HOSPITAL PRACTICE, 1978, 13 (09): : 95 - &
  • [46] MicroRNAs in drug-induced liver injury
    Goldring, C.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S25 - S25
  • [47] Drug-induced chronic liver injury
    Dakhoul, Lara
    Ghabril, Marwan
    Chalasani, Naga
    JOURNAL OF HEPATOLOGY, 2018, 69 (01) : 248 - 250
  • [48] The pathogenesis of drug-induced liver injury
    Lee, Sun-Jae
    Lee, Youn Ju
    Park, Kwan-Kyu
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (10) : 1175 - 1185
  • [49] DRUG-INDUCED LIVER-INJURY
    VANBERGEHENEGOUWEN, GP
    VOGTEN, AJM
    NETHERLANDS JOURNAL OF MEDICINE, 1980, 23 (01): : 23 - 32
  • [50] Drug-induced liver injury in obesity
    Fromenty, Bernard
    JOURNAL OF HEPATOLOGY, 2013, 58 (04) : 824 - 826